HitGen (SHSE:688222) Institutional Ownership: 3.75% (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688222 HitGen Inc SHSE:688222
89 GF Score
Price ¥31.67
GF Value ¥28.95
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is HitGen Institutional Ownership?

HitGen SHSE:688222 +0.25% 89 Institutional Ownership is 3.75% as of Sep. 07, 2026. GuruFocus rates SHSE:688222 with a GF Score™ of 89/100 and a GF Value™ of ¥28.95 (Fairly Valued). The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, HitGen's institutional ownership is 3.75%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, HitGen's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, HitGen's Float Percentage Of Total Shares Outstanding is 0.00%.

HitGen Institutional Ownership Historical Data

* Premium members only.

The historical data trend for HitGen's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HitGen Institutional Ownership Chart

HitGen Historical Data

The historical data trend for HitGen can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 1.86 4.15 4.17 4.14 3.97 3.98 3.98 3.88 3.91 3.75
SHSE:688222
89GF Score
HitGen Inc SHSE:688222
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HitGen Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 3.75% mean?
HitGen (SHSE:688222) has a Institutional Ownership of 3.75% as of Sep. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on HitGen and its competitors.
Is HitGen's Institutional Ownership too high?
HitGen's current Institutional Ownership is 3.75%. Overall, HitGen has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HitGen's Institutional Ownership compare to VRTX and REGN?
HitGen's Institutional Ownership of 3.75% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on HitGen and its competitors. HitGen's current Institutional Ownership is 3.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HitGen stock overvalued right now?
Based on GuruFocus' analysis, HitGen (SHSE:688222) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.95, compared to a current price of ¥31.67 — trading 9.4% above its estimated fair value. The current Institutional Ownership is 3.75%. HitGen's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For HitGen (SHSE:688222), the current Institutional Ownership is 3.75% as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HitGen (SHSE:688222) Overvalued in 2026?

Based on GuruFocus' analysis, HitGen stock appears to be overvalued. The current stock price of ¥31.67 is trading 9.4% above its estimated GF Value™ of ¥28.95. GuruFocus considers HitGen to be Fairly Valued.

Key valuation signals for SHSE:688222:

  • Institutional Ownership: 3.75%
  • GF Value™: ¥28.95 vs. price of ¥31.67 (9.4% above fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the SHSE:688222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HitGen Business Description

Address Section 2, Biocity Middle Road, Chengdu Tianfu International Biological City, No. 18, Shuangliu District, Sichuan Province, Chengdu, CHN, 610093
HitGen Inc is dedicated to building a world-class biopharmaceutical enterprise. Its mission is to advance human health and quality of life. It provides therapeutic solutions to address unmet medical needs. Centered on its internationally DEL (DNA-encoded Library) technology, the Company has expanded into Fragment-Based Drug Discovery and Structure-Based Drug Design and a suite of complementary platforms based on Oligonucleotide-based Therapeutics, Targeted Proximity Drugs, and Cyclic Peptidomimetics. The group has developed HAILO, a proprietary "DEL+AI+Automation" molecular optimization platform, thereby establishing a distinctive novel molecule discovery engine that delivers both therapeutic molecules and tool molecules to the world-wide pharmaceutical industry.
89GF Score

Get the complete analysis for SHSE:688222

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.67
Price
¥28.95
GF Value